Neslusan Cheryl, Chen Yen-Wen, Sharma Mohit, Voelker Jennifer
Janssen Scientific Affairs, LLC, Titusville, NJ, USA.
Mu Sigma Business Solutions Pvt. Ltd., Bengaluru, India.
J Med Econ. 2023 Jan-Dec;26(1):1-10. doi: 10.1080/13696998.2022.2133321.
Using a national electronic health records (EHR) database, the current study describes treatments, depression severity, and health care resource utilization (HRU) among patients with major depressive disorder (MDD) and acute suicidal ideation or behavior (MDSI) prior to, during, and following a suicide-related event in the United States.
This retrospective matched cohort study used data collected from the Optum EHR de-identified database for patients with diagnosis codes for MDD and acute suicidal ideation or behavior and a propensity score-matched cohort of patients without MDD or a suicide-related event. The study period was 31 October 2015-30 September 2019. MDD-related treatments and 9-item Patient Health Questionnaire (PHQ-9) scores, when available, were assessed at the first health care encounter for a suicide-related event (index period), 12 months before (pre-period), and 6 months after (post-period). All-cause and MDD-related HRU were assessed during the post-period.
The mean (standard deviation) age of patients with MDSI was 39 (16) years; 55.0% were female. Index events occurred as follows: inpatient stay, 38.9%; observation unit stay, 4.6%; emergency department (ED) visit, 46.5%; and outpatient visit, 10.1%. Antidepressants and psychotherapy were the most common pharmacologic and nonpharmacologic treatments, respectively, prescribed during the pre- (31.3%, 9.5%, respectively) and index (41.2%, 18.7%, respectively) periods. Post-period data ( = 40,261) revealed only 43.4% received an antidepressant and 20.5% had psychotherapy after the suicide-related event. Few patients had PHQ-9 scores recorded during the pre- (4.4%), index (1.3%), and post- (7.6%) periods. During the post-period, 11.8%, 5.0%, and 33.1% of patients had ≥1 all-cause inpatient stay, observation unit stay, and ED visit, respectively; 61.0% had ≥1 all-cause and 33.4% ≥1 MDD-related outpatient visit. Most patients with MDSI and an inpatient encounter or ED visit were discharged to home or self-care (65.4%). Odds of an all-cause hospital encounter during the post-period were higher for patients with versus without MDSI (by 30.1, 33.5, and 33.9 times for inpatient stay, ED visit, and observation unit stay, respectively).
This analysis highlights an opportunity to improve outcomes for this vulnerable population. More complete data on patient outcomes is needed to inform strategies designed to optimize screening and treatment.
本研究利用国家电子健康记录(EHR)数据库,描述了美国重度抑郁症(MDD)合并急性自杀意念或行为(MDSI)患者在自杀相关事件之前、期间及之后的治疗情况、抑郁严重程度和医疗资源利用(HRU)情况。
这项回顾性匹配队列研究使用了从Optum EHR去识别数据库中收集的数据,该数据库包含患有MDD和急性自杀意念或行为诊断代码的患者,以及一个倾向评分匹配的无MDD或自杀相关事件的患者队列。研究时间段为2015年10月31日至2019年9月30日。在与自杀相关事件的首次医疗就诊(索引期)、之前12个月(前期)和之后6个月(后期),评估了与MDD相关的治疗和9项患者健康问卷(PHQ-9)评分(若有)。在后期评估了全因和与MDD相关的HRU。
患有MDSI的患者的平均(标准差)年龄为39(16)岁;55.0%为女性。索引事件发生情况如下:住院,38.9%;观察单元留观,4.6%;急诊科(ED)就诊,46.5%;门诊就诊,10.1%。抗抑郁药和心理治疗分别是前期(分别为31.3%、9.5%)和索引期(分别为41.2%、18.7%)最常用的药物和非药物治疗方法。后期数据(n = 40,261)显示,自杀相关事件后只有43.4%的患者接受了抗抑郁药治疗,20.5%的患者接受了心理治疗。在前期(4.4%)、索引期(1.3%)和后期(7.6%)记录PHQ-9评分的患者很少。在后期,分别有11.8%、5.0%和33.1%的患者有≥1次全因住院、观察单元留观和ED就诊;61.